Genes-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2019-01-12 ms7242751882637620

审稿速度:2.0
经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018

68 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2017-04-06 1861eae240m

朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表::
研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态...

jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态...

280 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2015-12-18 小莹

请问这个如何投稿，可否发一下杂志主页或投稿邮箱

282 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2016-05-25 fjswrww

审稿速度:1.0 | 投稿命中率:50.0
经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！

297 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2018-09-05 ms7999216884373889

3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！

77 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2019-11-21 ms1560573802851675

9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2020-12-28 1e0cf3e5m18(暂无匿称)

审稿速度:2.0 | 投稿命中率:25.0
经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间

91 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2023-03-15 ms7991353960699732 来自河南省

偏重的研究方向：生物信息学;非肿瘤;心血管
经验分享：纯生信，两个工作日被拒，是挺快的

31 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2022-05-23 ms1000001833329884

一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了

74 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=849217, encodeId=838784921ee9, content=审稿速度:2.0 经验分享：投的genes的special issue，received: 3 may 2018 / revised: 28 may 2018 / accepted: 12 june 2018 / published: 18 june 2018 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f3f5413986, createdName=ms7242751882637620, createdTime=Sat Jan 12 22:53:12 CST 2019, time=2019-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=535184, encodeId=39e0535184ea, content=朋友，您的pending editor decision一共用了多久啊jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., beContent=jonsen 2015-09-29 发表:: 研究方向：基因组学;基因蛋白功能研究; 审稿时间：约1个月虽然审稿只用了一个多月，但是pending editor decision已经持续快两周了，还是这个状态..., objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dd302046482, createdName=1861eae240m, createdTime=Thu Apr 06 08:57:00 CST 2017, time=2017-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517670, encodeId=d3e151e67092, content=请问这个如何投稿，可否发一下杂志主页或投稿邮箱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=282, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f0c31662674, createdName=小莹, createdTime=Fri Dec 18 14:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522837, encodeId=dd9f52283e47, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：有上升趋势，审稿挺严的。不过好好回答，拒稿不多！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=297, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87661707381, createdName=fjswrww, createdTime=Wed May 25 12:41:00 CST 2016, time=2016-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847022, encodeId=409284e02202, content=3个审稿人，很专业很负责。感觉文章要有一定的工作量和新意才行。如果需要补实验，或大修，则可能据稿或据稿建议再投！文章校订、编辑都非常认真负责、规范！长期看好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6a75413984, createdName=ms7999216884373889, createdTime=Wed Sep 05 20:05:09 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855127, encodeId=ad1f85512ef8, content=9月28投稿，经历了1次大修，2次小修，11月20日终于published,评审和编委都很认真负责，提的意见对论文水平都有所提高，该杂志对语言要求还是挺高的。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c55a5414028, createdName=ms1560573802851675, createdTime=Thu Nov 21 11:30:14 CST 2019, time=2019-11-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911547, encodeId=570891154ed9, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：坚决不收中国医院的文章，对来自非医院的中国文章也不友好，很挑剔，急着毕业慎重投稿，否则耗费时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6be81931781, createdName=1e0cf3e5m18(暂无匿称), createdTime=Mon Dec 28 09:51:41 CST 2020, time=2020-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119517, encodeId=c3a4211951e30, content=偏重的研究方向：生物信息学;非肿瘤;心血管 经验分享：纯生信，两个工作日被拒，是挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/g?b=oidb&k=fK7WwP8awWHT6WWchYVbxA&s=100&t=1555162348, createdBy=4f795155072, createdName=ms7991353960699732, createdTime=Wed Mar 15 13:45:44 CST 2023, time=2023-03-15, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221667, encodeId=4f8e122166e0b, content=一篇质量还行的肿瘤生信3天模板拒，后来投了个分更高的期刊中了。但是genes近期也有极其低级的肿瘤生信文章，怎么过的初审？一看不是大陆，不是医院，懂了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8b5460993, createdName=ms1000001833329884, createdTime=Mon May 23 03:36:53 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094674, encodeId=44c420946e4fb, content=偏重的研究方向：基因 经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150707/IMG559BCB2F291DE5912.jpg, createdBy=7b921631412, createdName=laal, createdTime=Wed Oct 19 10:21:17 CST 2022, time=2022-10-19, status=1, ipAttribution=)]

2022-10-19 laal

偏重的研究方向：基因
经验分享：医院的文章感觉是模板据，连投了两个MDPI的杂志

24 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务